OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 88

Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Elliot D. Mock, Berend Gagestein, Mario van der Stelt
Progress in Lipid Research (2022) Vol. 89, pp. 101194-101194
Open Access | Times Cited: 87

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 57

Radiopharmaceuticals and their applications in medicine
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6

Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis
Hailey Cuddihey, Wallace K. MacNaughton, Keith A. Sharkey
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 14, Iss. 4, pp. 947-963
Open Access | Times Cited: 48

AP-4-mediated axonal transport controls endocannabinoid production in neurons
Alexandra K. Davies, Julian E. Alecu, M. L. ZIEGLER, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42

Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 27

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29

The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies
Samantha M. Ayoub, Breanna Holloway, Alannah Miranda, et al.
Current HIV/AIDS Reports (2024) Vol. 21, Iss. 3, pp. 87-115
Open Access | Times Cited: 6

The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
Robert Ramer, Felix Wittig, Burkhard Hinz
Cancers (2021) Vol. 13, Iss. 22, pp. 5701-5701
Open Access | Times Cited: 34

Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Stuart M. Brierley, Beverley Greenwood‐Van Meerveld, Giovanni Sarnelli, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 5-25
Closed Access | Times Cited: 26

Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
Vincenzo Pota, Pasquale Sansone, Sara De Sarno, et al.
Behavioural Neurology (2024) Vol. 2024, pp. 1-23
Open Access | Times Cited: 5

The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways
Muthanna Sultan, Hasan Alghetaa, Amira Mohammed, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27

Reactive chemistry for covalent probe and therapeutic development
R. Justin Grams, Ku‐Lung Hsu
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 3, pp. 249-262
Open Access | Times Cited: 22

The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles
Verena M. Straub, Benjámin Barti, Sebastian T. Tandar, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 8
Open Access

Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development
Roberta Ottria, Silvana Casati, Ornella Xynomilakis, et al.
Molecules (2025) Vol. 30, Iss. 7, pp. 1605-1605
Open Access

Acne Treatment Based on Cannabinoids: Efficacy and Legislation Perspectives
Hilarión Araujo, Teresa Santos, Flávia Sobreira Mendonça Gonçalves, et al.
Journal of Skin and Stem Cell (2025) Vol. 12, Iss. 1
Open Access

Inhibition of endocannabinoid hydrolases MAGL, FAAH and ABHD6 by AKU-005 reduces ex vivo cortical spreading depression
Flavia Brugia, Konstantin Ivanov, Auni Aroviita, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access

Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression
Qingjing Hao, Junwei Shi, Zhilan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116285-116285
Closed Access | Times Cited: 3

The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy
Iddrisu Ibrahim, Joseph Ayariga, Junhuan Xu, et al.
(2024)
Open Access | Times Cited: 3

A comprehensive molecular analysis of cannabidiol: From solid state to antioxidant potential
Antônio S. N. Aguiar, Cristiano M. Veloso, Yuri B.R. Tejota, et al.
Computational and Theoretical Chemistry (2024), pp. 114890-114890
Closed Access | Times Cited: 3

TRPV1 blockers as potential new treatments for psychiatric disorders
Lia P. Iglesias, Daniele C. Aguiar, Fabrício A. Moreira
Behavioural Pharmacology (2020) Vol. 33, Iss. 1, pp. 2-14
Closed Access | Times Cited: 25

Page 1 - Next Page

Scroll to top